Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5651
British American Tobacco
BTI
$131B
| $17K | ﹤0.01% |
312
-28,620
| -99% | -$1.58M |
|
5652
Enanta Pharmaceuticals
ENTA
$366M
| $17K | ﹤0.01% |
368
-371
| -50% | -$14.4K |
|
5653
Fortuna Silver Mines
FSM
$2.55B
| $17K | ﹤0.01% |
5,542
+42
| +0.8% | +$158 |
|
5654
PUT
Foster
FSTR
$430M
| $17K | ﹤0.01% |
+500
| New | +$20.4K |
|
5655
Green Dot
GDOT
$743M
| $17K | ﹤0.01% |
879
-56
| -6% | -$909 |
|
5656
Heron Therapeutics
HRTX
$93.9M
| $17K | ﹤0.01% |
521
-183
| -26% | -$3.44K |
|
5657
CALL
Intrepid Potash
IPI
$456M
| $17K | ﹤0.01% |
150
-140
| -48% | -$16.6K |
|
5658
CALL
Robert Half
RHI
$3.87B
| $17K | ﹤0.01% |
300
-1,300
| -81% | -$74.4K |
|
5659
Safety Insurance
SAFT
$1.52B
| $17K | ﹤0.01% |
290
-100
| -26% | -$5.8K |
|
5660
Safe Bulkers
SB
$795M
| $17K | ﹤0.01% |
5,725
-443
| -7% | -$1.54K |
|
5661
TFS Financial
TFSL
$5.16B
| $17K | ﹤0.01% |
1,048
-3,150
| -75% | -$47.4K |
|
5662
Tronox
TROX
$932M
| $17K | ﹤0.01% |
1,216
-13,482
| -92% | -$254K |
|
5663
TherapeuticsMD
TXMD
$23.5M
| $17K | ﹤0.01% |
49
-22
| -31% | -$7.76K |
|
5664
Universal Technical Institute
UTI
$2.16B
| $17K | ﹤0.01% |
2,204
-292
| -12% | -$2.64K |
|
5665
Virtus Investment Partners
VRTS
$1.06B
| $17K | ﹤0.01% |
131
-80
| -38% | -$10.4K |
|
|
MAGN
5666
Magnera Corp
MAGN
$472M
| $17K | ﹤0.01% |
63
-637
| -91% | -$202K |
|
|
ITCI
5667
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $17K | ﹤0.01% |
534
-3,017
| -85% | -$76.5K |
|
|
STAY
5668
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $17K | ﹤0.01% |
+949
| New | +$18.8K |
|
|
LBY
5669
DELISTED
Libbey, Inc.
LBY
| $17K | ﹤0.01% |
418
-227
| -35% | -$9.18K |
|
|
FRED
5670
DELISTED
Fred's Inc
FRED
| $17K | ﹤0.01% |
887
-4,564
| -84% | -$81.2K |
|
|
FCB
5671
DELISTED
FCB Financial Holdings, Inc.
FCB
| $17K | ﹤0.01% |
536
-39,741
| -99% | -$1.14M |
|
|
GIMO
5672
DELISTED
Gigamon Inc.
GIMO
| $17K | ﹤0.01% |
523
-207
| -28% | -$6.11K |
|
|
KCG
5673
PUT
DELISTED
KCG Holdings, Inc.
KCG
| $17K | ﹤0.01% |
1,400
-19,500
| -93% | -$254K |
|
|
CNV
5674
DELISTED
CNOVA N.V.
CNV
| $17K | ﹤0.01% |
+3,374
| New | +$20.1K |
|
|
AEGR
5675
DELISTED
Aegerion Pharmaceuticals
AEGR
| $17K | ﹤0.01% |
984
-25,490
| -96% | -$552K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.